Teladoc Health, a global leader in virtual healthcare, reported a mixed financial performance for the quarter ended September 30, 2024. The company saw a decrease in total consolidated revenue to $640.5 million, down 3% from $660.2 million in the same quarter of the previous year. The decline was primarily attributed to lower revenue in the BetterHelp segment. Despite this, Teladoc Health Integrated Care segment's revenue increased by 2% to $383.7 million, with an 8% rise in Adjusted EBITDA to $68 million. The company's net loss improved, decreasing to $33.3 million from $57.1 million year-on-year, a 42% reduction. Adjusted EBITDA for the company was down 6% to $83.3 million. Teladoc Health's future plans include continuing to innovate services and enhance member experiences, aiming to make virtual care the first step...Show More

Teladoc Health, a global leader in virtual healthcare, reported a mixed financial performance for the quarter ended September 30, 2024. The company saw a decrease in total consolidated revenue to $640.5 million, down 3% from $660.2 million in the same quarter of the previous year. The decline was primarily attributed to lower revenue in the BetterHelp segment. Despite this, Teladoc Health Integrated Care segment's revenue increased by 2% to $383.7 million, with an 8% rise in Adjusted EBITDA to $68 million. The company's net loss improved, decreasing to $33.3 million from $57.1 million year-on-year, a 42% reduction. Adjusted EBITDA for the company was down 6% to $83.3 million. Teladoc Health's future plans include continuing to innovate services and enhance member experiences, aiming to make virtual care the first step in healthcare journeys. The company's performance is influenced by factors such as membership growth, chronic care program enrollment, and average monthly revenue per member. Teladoc Health recorded a significant non-cash goodwill impairment charge of $790 million due to a decrease in share price and changes in the BetterHelp unit's operating results. The company believes its existing cash and cash equivalents of $1.24 billion will support its working capital and capital expenditure needs for at least the next 12 months.